Updates in the care of the alloimmunized pregnant patient: A transfusion medicine and clinical laboratory perspective
American Journal of Clinical Pathology · 2023
DOI: 10.1093/ajcp/aqad083 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical Pathology, 2023. Verfasst von Elizabeth Abels und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, US. Hauptthemen laut MEDLINE: Transfusion Medicine, Clinical Laboratory Services. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
Red blood cell (RBC) alloimmunization usually occurs following exposure to allogeneic blood, most commonly via transfusion or pregnancy. Alloantibodies may develop to any of the hundreds of RBC antigens, although a subset is more immunogenic and clinically significant. Individuals with childbearing potential and pregnant individuals represent a particularly challenging population to manage with regard to RBC alloimmunization due to both the potential fetal risk posed by maternal alloantibodies and the impact that alloantibodies may have on obtaining compatible blood. The American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin 192 addresses the management of alloimmunization during pregnancy.1 It contains recommendations supported by referenced studies, including methods by which paternal antigen status should be determined and the use of antibody titers to assess fetal risk of hemolytic disease of the fetus and newborn (HDFN) following identification of RBC alloantibodies. However, some transfusion medicine- and laboratory-specific recommendations are incorrect and/or outdated, which necessitate a review of the bulletin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, US.
- Division of Transfusion Medicine and Hemostasis, Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, US.
- Department of Pathology, University of California San Diego, La Jolla, CA, US.
- Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, TN, US.
- Department of Laboratory Medicine, Mayo Clinic, Rochester, MN, US.
- Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, CT, US.
ORCID-Profile: Jennifer S Woo, Jeremy W Jacobs
Zitieren
APA
Abels, E., Adkins, B. D., Allen, E. S., Booth, G. S., DiGuardo, M. A., Ding, J. J., Guarente, J., Klein, M., Stephens, L. D., Tormey, C. A., Woo, J. S., & Jacobs, J. W. (2023). Updates in the care of the alloimmunized pregnant patient: A transfusion medicine and clinical laboratory perspective. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqad083
Vancouver
Abels E, Adkins BD, Allen ES, Booth GS, DiGuardo MA, Ding JJ, et al. Updates in the care of the alloimmunized pregnant patient: A transfusion medicine and clinical laboratory perspective. American Journal of Clinical Pathology. 2023. doi:10.1093/ajcp/aqad083
BibTeX
@article{Abels2023,
author = {Abels, Elizabeth and Adkins, Brian D and Allen, Elizabeth S and Booth, Garrett S and DiGuardo, Margaret A and Ding, Jia Jennifer and Guarente, Juliana and Klein, Monica and Stephens, Laura D and Tormey, Christopher A and Woo, Jennifer S and Jacobs, Jeremy W},
title = {Updates in the care of the alloimmunized pregnant patient: A transfusion medicine and clinical laboratory perspective},
journal = {American Journal of Clinical Pathology},
year = {2023},
doi = {10.1093/ajcp/aqad083}
}
EUVIMED